Kidney Research UK, Centre for Complement and Inflammation Research, Imperial College London, London, United Kingdom.
Semin Nephrol. 2013 Nov;33(6):493-507. doi: 10.1016/j.semnephrol.2013.08.002.
C3 glomerulopathy refers to those renal lesions characterized histologically by predominant C3 accumulation within the glomerulus, and pathogenetically by aberrant regulation of the alternative pathway of complement. Dense deposit disease is distinguished from other forms of C3 glomerulopathy by its characteristic appearance on electron microscopy. The extent to which dense deposit disease also differs from other forms of C3 glomerulopathy in terms of clinical features, natural history, and outcomes of treatment including renal transplantation is less clear. We discuss the pathophysiology of C3 glomerulopathy, with evidence for alternative pathway dysregulation obtained from affected individuals and complement factor H (Cfh)-deficient animal models. Recent linkage studies in familial C3 glomerulopathy have shown genomic rearrangements in the Cfh-related genes, for which the novel pathophysiologic concept of Cfh deregulation has been proposed.
C3 肾小球病是指那些在组织学上以肾小球内 C3 蓄积为主,在发病机制上以补体替代途径异常调节为特征的肾脏病变。密堆积病在电子显微镜下的特征性表现使其与其他 C3 肾小球病区分开来。密堆积病在临床表现、自然病程和治疗结果(包括肾移植)方面与其他 C3 肾小球病的差异程度尚不清楚。我们讨论了 C3 肾小球病的病理生理学,从受影响的个体和补体因子 H(Cfh)缺陷动物模型中获得了替代途径失调的证据。最近在家族性 C3 肾小球病中的连锁研究显示 Cfh 相关基因的基因组重排,为此提出了 Cfh 失调的新病理生理概念。